PDK1 and cancer: Considering that glycolysis-dependent cancer cells are more susceptible to PDK1 inhibition, leading to increased cellular oxidative stress and apoptosis27, we hypothesized that EGFR C797S mutant cells, characterized by elevated glycolytic activity relative to that in EGFR double-mutant cells, would exhibit increased susceptibility to PDK1 inhibitors.